Bovine milk-derived exosomes for drug delivery

Cancer Letters

Volumn 371, Issue 1, 2016, Pages 48-61

  Munagala, Radha ^a,b   Aqil, Farrukh ^a,b   Jeyabalan, Jeyaprakash ^b   Gupta, Ramesh C ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Chemopreventive agents; Chemotherapeutic drugs; Drug delivery; Milk derived exosomes; Tumor targeting

Indexed keywords

DRUG CARRIER; FOLIC ACID; ANTINEOPLASTIC AGENT; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG SAFETY; EXCIPIENT COMPATIBILITY; EXOSOME; FEMALE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; BOVINE; CELL PROLIFERATION; DRUG EFFECTS; DRUG SCREENING; HUMAN; IMMUNOLOGY; LUNG NEOPLASMS; MALE; MEDICINAL CHEMISTRY; METABOLISM; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; SOLUBILITY; TISSUE DISTRIBUTION; TOXICITY; TUMOR CELL LINE;

ADMINISTRATION, ORAL; ANIMALS; ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; EXOSOMES; FEMALE; FOLIC ACID; HUMANS; IMMUNE TOLERANCE; LUNG NEOPLASMS; MALE; MICE, NUDE; MILK; NANOPARTICLES; SOLUBILITY; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84951831545     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.10.020     Document Type: Article

References (51)

1. Jabir N.R., Tabrez S., Ashraf G.M., Shakil S., Damanhouri G.A., Kamal M.A. Nanotechnology-based approaches in anticancer research. Int. J. Nanomedicine 2012, 7:4391-4408.
2. Lim E.K., Jang E., Lee K., Haam S., Huh Y.M. Delivery of cancer therapeutics using nanotechnology. Pharmaceutics 2013, 5:294-317.
3. Barenholz Y. Doxil(R) - the first FDA-approved nano-drug: lessons learned. J. Control Release 2012, 160:117-134.
4. Ciruelos E., Jackisch C. Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancer. Expert Rev. Anticancer Ther 2014, 14:511-521.
5. Saif M.W. U.S. Food and Drug Administration approves paclitaxel protein-bound particles (Abraxane(R)) in combination with gemcitabine as first-line treatment of patients with metastatic pancreatic cancer. JOP 2013, 14:686-688.
6. Bamrungsap S., Zhao Z., Chen T., Wang L., Li C., Fu T., et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Nanomedicine 2012, 7:1253-1271.
7. Desai N. Challenges in development of nanoparticle-based therapeutics. AAPS J 2012, 14:282-295.
8. Lai R.C., Yeo R.W., Tan K.H., Lim S.K. Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol. Adv 2013, 31:543-551.
9. Kooijmans S.A., Vader P., van Dommelen S.M., van Solinge W.W., Schiffelers R.M. Exosome mimetics: a novel class of drug delivery systems. Int. J. Nanomedicine 2012, 7:1525-1541.
10. Lakhal S., Wood M.J. Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers. Bioessays 2011, 33:737-741.
11. Thery C., Amigorena S., Raposo G., Clayton A. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids, Current Protocols in Cell Biology/Editorial Board 2006, 22. Chapter 3, Unit 3. J.S. Bonifacino (Ed.).
12. Admyre C., Johansson S.M., Qazi K.R., Filen J.J., Lahesmaa R., Norman M., et al. Exosomes with immune modulatory features are present in human breast milk. J. Immunol 2007, 179:1969-1978.
13. Hata T., Murakami K., Nakatani H., Yamamoto Y., Matsuda T., Aoki N. Isolation of bovine milk-derived microvesicles carrying mRNAs and microRNAs. Biochem. Biophys. Res. Commun 2010, 396:528-533.
14. El-Andaloussi S., Lee Y., Lakhal-Littleton S., Li J., Seow Y., Gardiner C., et al. Exosome-mediated delivery of siRNA in vitro and in vivo. Nat. Protoc 2012, 7:2112-2126.
15. van den Boorn J.G., Schlee M., Coch C., Hartmann G. SiRNA delivery with exosome nanoparticles. Nat. Biotechnol 2011, 29:325-326.
16. Sun D.M., Zhuang X.Y., Xiang X.Y., Liu Y.L., Zhang S.Y., Liu C.R., et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther 2010, 18:1606-1614.
17. Haug A., Hostmark A.T., Harstad O.M. Bovine milk in human nutrition - a review. Lipids Health Dis 2007, 6:25.
18. Dragovic R.A., Gardiner C., Brooks A.S., Tannetta D.S., Ferguson D.J.P., Hole P., et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomed.-Nanotechnol 2011, 7:780-788.
19. Munagala R., Kausar H., Munjal C., Gupta R.C. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis 2011, 32:1697-1705.
20. Paul P.K., Gupta S.K., Bhatnagar S., Panguluri S.K., Darnay B.G., Choi Y., et al. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J. Cell Biol 2010, 191:1395-1411.
21. Bansal S.S., Vadhanam M.V., Gupta R.C. Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin. Pharm. Res 2011, 28:1121-1130.
22. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
23. Lee Y., El Andaloussi S., Wood M.J. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum. Mol. Genet 2012, 21:R125-R134.
24. Mathivanan S., Simpson R.J. ExoCarta: a compendium of exosomal proteins and RNA. Proteomics 2009, 9:4997-5000.
25. Taylor D.D., Gercel-Taylor C. The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids. Gene. Front 2013, 4:142.
26. Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A., et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol 2012, 14:677-685.
27. Kosaka N., Izumi H., Sekine K., Ochiya T. microRNA as a new immune-regulatory agent in breast milk. Silence 2010, 1:7.
28. Lu L.F., Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009, 127:291-298.
29. Corrado C., Raimondo S., Chiesi A., Ciccia F., De Leo G., Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int. J. Mol. Sci 2013, 14:5338-5366.
30. Johnsen K.B., Gudbergsson J.M., Skov M.N., Pilgaard L., Moos T., Duroux M. A comprehensive overview of exosomes as drug delivery vehicles - Endogenous nanocarriers for targeted cancer therapy. Bba.-Rev. Cancer 2014, 1846:75-87.
31. Vlassov A.V., Magdaleno S., Setterquist R., Conrad R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Bba.-Gen. Subjects 2012, 1820:940-948.
32. Tauro B.J., Greening D.W., Mathias R.A., Ji H., Mathivanan S., Scott A.M., et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 2012, 56:293-304.
33. Batista B.S., Eng W.S., Pilobello K.T., Hendricks-Munoz K.D., Mahal L.K. Identification of a conserved glycan signature for microvesicles. J. Proteome Res 2011, 10:4624-4633.
34. Wolf T., Baier S.R., Zempleni J. The intestinal transport of bovine milk exosomes is mediated by endocytosis in human colon carcinoma Caco-2 cells and rat small intestinal IEC-6 cells. J. Nutr 2015, 145:2201-2206.
35. Izumi H., Tsuda M., Sato Y., Kosaka N., Ochiya T., Iwamoto H., et al. Bovine milk exosomes contain microRNA and mRNA and are taken up by human macrophages. J. Dairy Sci 2015, 98:2920-2933.
36. Reinhardt T.A., Lippolis J.D., Nonnecke B.J., Sacco R.E. Bovine milk exosome proteome. J. Proteomics 2012, 75:1486-1492.
37. Pieters B.C., Arntz O.J., Bennink M.B., Broeren M.G., van Caam A.P., Koenders M.I., et al. Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory TGF-beta. PLoS ONE 2015, 10:e0121123.
38. Yamada T., Inoshima Y., Matsuda T., Ishiguro N. Comparison of methods for isolating exosomes from bovine milk. J Vet. Med. Sci 2012, 74:1523-1525.
39. Arntz O.J., Pieters B.C., Oliveira M.C., Broeren M.G., Bennink M.B., de Vries M., et al. Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models. Mol. Nutr. Food Res 2015, 59:1701-1712.
40. Sheng H., Hassanali S., Nugent C., Wen L., Hamilton-Williams E., Dias P., et al. Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice. J. Immunol 2011, 187:1591-1600.
41. Estelles A., Sperinde J., Roulon T., Aguilar B., Bonner C., LePecq J.B., et al. Exosome nanovesicles displaying G protein-coupled receptors for drug discovery. Int. J. Nanomedicine 2007, 2:751-760.
42. Rahman M.J., Regn D., Bashratyan R., Dai Y.D. Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice. Diabetes 2014, 63:1008-1020.
43. Mitchell J.P., Court J., Mason M.D., Tabi Z., Clayton A. Increased exosome production from tumour cell cultures using the Integra CELLine culture system. J. Immunol. Methods 2008, 335:98-105.
44. EL Andaloussi S., Mager I., Breakefield X.O., Wood M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov 2013, 12:347-357.
45. Sun Q., Chen X., Yu J., Zen K., Zhang C.Y., Li L. Immune modulatory function of abundant immune-related microRNAs in microvesicles from bovine colostrum. Protein Cell 2013, 4:197-210.
46. Zhou Q., Li M., Wang X., Li Q., Wang T., Zhu Q., et al. Immune-related microRNAs are abundant in breast milk exosomes. Int. J. Biol. Sci 2012, 8:118-123.
47. Melnik B.C., John S.M., Schmitz G. Milk: an exosomal microRNA transmitter promoting thymic regulatory T cell maturation preventing the development of atopy?. J. Transl. Med 2014, 12:43.
48. Yang T., Martin P., Fogarty B., Brown A., Schurman K., Phipps R., et al. Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio. Pharm. Res 2015, 32:2003-2014.
49. Tian Y.H., Li S.P., Song J., Ji T.J., Zhu M.T., Anderson G.J., et al. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 2014, 35:2383-2390.
50. Fuhrmann G., Serio A., Mazo M., Nair R., Stevens M.M. Active loading into extracellular vesicles significantly improves the cellular uptake and photodynamic effect of porphyrins. J. Control. Release 2015, 205:35-44.
51. Chen S., Zhao X., Chen J., Chen J., Kuznetsova L., Wong S.S., et al. Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release. Bioconjug. Chem 2010, 21:979-987.